Alcyone Therapeutics
About:
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Website: https://alcyonetx.com
Top Investors: RTW Investments
Description:
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities and overcome challenges for CNS therapy development.
Total Funding Amount:
$23M
Headquarters Location:
Lowell, Massachusetts, United States
Founded Date:
2010-01-01
Contact Email:
Info(AT)alcyonetx.com
Founders:
David Donabedian, PhD, PJ Anand
Number of Employees:
11-50
Last Funding Date:
2021-06-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai